Targeting S100A4 siRNA has reported to decrease proliferation and induce apoptosis in anaplastic thyroid cancer (ATC) cells in vitro and in vivo, supporting that S100A4 is responsible for increased survival [43]. Here, S100A4 is linked to thyroid gland undifferentiated (anaplastic) carcinoma.